DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cerubidine (Daunorubicin) - Pleural Effusion - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pleural Effusion (7)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cerubidine (Daunorubicin) where reactions include pleural effusion. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cerubidine side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-04

Patient: 55 year old male

Reactions: Transfusion-Related Acute Lung Injury, Interstitial Lung Disease, Pleural Effusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 500 mg/m2 (1 g), 1x/day
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Neupogen
    Dosage: 5 ug/kg (450 ug), 1x/day
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-03-01

Perikabiven 1200
    Dosage: unk
    Indication: Parenteral Nutrition
    Start date: 2012-02-29
    End date: 2012-03-01

Cerubidine
    Dosage: 60 mg/m2 (120 mg), 1x/day
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Other drugs received by patient: Lasix; Primperan TAB; Gaviscon; Zofran; Tiorfan; Tramadol; Paracetamol; Periferalgan; Ceftriaxone; Aciclovir; Hydrea; Folic Acid



Possible Cerubidine side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-22

Patient: 55 year old male

Reactions: Abdominal Pain, Hyperbilirubinaemia, Cholestasis, Pyrexia, Aplasia, Lung Disorder, Diarrhoea, Pleural Effusion, Acute Respiratory Distress Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neupogen
    Dosage: 450 mug, unk
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-03-02

Primperan TAB
    Dosage: unk
    Indication: Vomiting
    Start date: 2012-02-24
    End date: 2012-03-01

Cytarabine
    Dosage: 1 g, qd
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Cerubidine
    Dosage: 120 mg, unk
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Other drugs received by patient: Gaviscon; Acetaminophen; Perikabiven; Ondansetron; Tramadol Hydrochloride; Hydrea; Kabiven; Vancomycin; Folic Acid; Lasix; Ceftriaxone Sodium; Acyclovir; Rovamycine / 00074401 /; Piperacilline Panpharma; Acetaminophen; Tiorfan



Possible Cerubidine side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-18

Patient: 55 year old male

Reactions: Abdominal Pain, Hyperbilirubinaemia, Cholestasis, Pyrexia, Aplasia, Lung Disorder, Diarrhoea, Pleural Effusion, Acute Respiratory Distress Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cerubidine
    Dosage: 120 mg, unk
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Primperan TAB
    Dosage: unk
    Indication: Vomiting
    Start date: 2012-02-24
    End date: 2012-03-01

Cytarabine
    Dosage: 1 g, qd
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-02-25

Neupogen
    Dosage: 450 mug, unk
    Indication: Acute Myelomonocytic Leukaemia
    Start date: 2012-02-23
    End date: 2012-03-02

Other drugs received by patient: Vancomycin; Acyclovir; Rovamycine / 00074401 /; Hydrea; Perikabiven; Ceftriaxone Sodium; Tiorfan; Kabiven; Folic Acid; Lasix; Ondansetron; Acetaminophen; Gaviscon; Acetaminophen; Piperacilline Panpharma; Tramadol Hydrochloride



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Generalised Oedema, Ascites, Pericardial Effusion, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cyclophosphamide
    Dosage: 780 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06

Cytarabine
    Dosage: 25 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14

Methotrexate
    Dosage: 12 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Vincristine
    Dosage: 1.2 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Kidrolase
    Dosage: 4800 iu, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Aplasia, Stomatococcal Infection, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Spleen Disorder, Oral Disorder, Sepsis, Hypoxia, Acute Respiratory Distress Syndrome, Pleural Effusion, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 25 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cerubidine
    Dosage: 31 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Methotrexate
    Dosage: 12 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Vincristine
    Dosage: 1.2 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Kidrolase
    Dosage: 4800 iu, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Cyclophosphamide
    Dosage: 780 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-02

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Ascites, Pericardial Effusion, Generalised Oedema, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Kidrolase
    Dosage: 4800 iu, unk
    Start date: 2011-10-06
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Cytarabine
    Dosage: 25 mg, unk
    Start date: 2011-10-10
    End date: 2011-10-14

Cyclophosphamide
    Dosage: 780 mg, unk
    Start date: 2011-10-06

Vincristine Sulfate
    Dosage: 1.2 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-10-21

Methotrexate
    Dosage: 12 mg, unk
    Start date: 2011-10-03
    End date: 2011-10-14



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-31

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Oral Disorder, Sepsis, Pleural Effusion, Hypoxia, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vincristine Sulfate
    Dosage: 1.2 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Cytarabine
    Dosage: 25 mg, unk
    Start date: 2011-10-10
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Methotrexate
    Dosage: 12 mg, unk
    Start date: 2011-10-03
    End date: 2011-10-14

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-10-21

Cyclophosphamide
    Dosage: 780 mg, unk
    Start date: 2011-10-06

Kidrolase
    Dosage: 4800 iu, unk
    Start date: 2011-10-06
    End date: 2011-10-14

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017